Scheme for Promotion of Research and Innovation in Pharma MedTech Sector (PRIP)
Objectives of the Scheme :-
- Transform Indian Pharma MedTech sector.
- Move from cost based to innovation-based growth.
- Strengthen the research infrastructure in the country.
- Promote industry-academia linkage for R&D in priority areas.
- Inculcate the culture of quality research and nurture our pool of scientists.
Scheme Categories
Category A aims to setup more National Institutes for Pharma Education & Research (NIPERs)
Category B aims to offer incentives to corporates for undertaking research. Category B has three subparts as under:-
- Selection of 9 established Pharma companies who are willing to carry out research in six priority areas with academic collaboration in Govt. institute of national repute to offer 35% Capex Subsidy for Research (capped at ₹ 125 Crores)
- Funding would be provided to Thirty research projects in six priority areas which are at successfully validated level (TRL 5) to reach TRL 9 @ 35% of the cost or ₹ 100 Cr whichever is less over a period of 5 years on the principle of benefit sharing.
- Funding would be provided to 125 research projects in six priority areas to help Indian startups and MSMEs to reach TRL 4.
Overall Financial Outlay – ₹ 5,000 Crores
Scheme Validity – 5 Years
To know more about the scheme, read our publication (Scheme_for_PRIP) or contact us
